HRA Radiation Assurance Opportunity: Medical Physics Expert (MPE) and Clinical Radiation Expert (CRE) Reviewer Registration
News
The HRA is currently inviting MPEs and CREs to register to become HRA Radiation Assurance Reviewers
Moving towards a consensus on platform trial designs
News
A collaborative workshop relating to definitions of complex trial designs was successfully held on 5 February 2018 in partnership with regulatory bodies (Health Research Authority, Medicines and Healthcare products Regulatory Agency (MHRA)) and other stakeholders including the research community (ECMC, Cancer Research UK, and Clinical Trials Units), devolved administrations and...
JING: Training the Next Generation 2018
News
In January 2018 over 100 people from across the ECMC network came to Manchester to attend the sixth annual two day Junior Investigator Network Group (JING) : Training the Next Generation event. This two day residential is aimed at junior investigators wishing to pursue and develop in the area of...
Roundup: Clinical development of drug-radiotherapy combinations workshop
News
The Combinations Alliance partners with the ECMC Network to drive new combination therapies, including drug-radiotherapy combinations. ECMC studies such as PIONEER and PARADIGM-2 have been previously highlighted as successes in this area. Representatives from the ECMC network have been part of a cross-disciplinary joint working group led by NCRI CTRad...
Q&A with Dr James Larkin
News
We spoke to Dr James Larkin about his appointment as a new Senior Clinical Advisor in clinical research for Cancer Research UK (CRUK). Dr Larkin is a consultant medical oncologist and clinical researcher at The Royal Marsden, specialising in the treatment of melanoma and kidney cancer. His research focuses on...
Showcasing the Capabilities of ECMC Manchester
Basic page
The above video showcases the key capabilities that Manchester ECMC has to offer, and which disease site groups we are focusing on. Within Manchester, our 6 major disease groups are: Lung, Breast, Melanoma, Gynaelogical, Prostate and Haematological. These disease groups are supported within our cross-cutting themes of Experimental Therapeutics, Biomarkers,...
HRA Radiation Assurance MPE and CRE Reviewer Recruitment
News
Due to the large number of applications received, the HRA are bringing forward the next round of recruitment for MPEs and CREs to register to become HRA Radiation Assurance Reviewers. The closing date for applications is Friday 6th April.
Resource for patient and public involvement in early phase cancer research
Basic page
The ECMC network Patient and Public Involvement (PPI) Group has written a booklet to support people affected by cancer who are taking part in PPI activities in early phase (Phase 1 and 2) cancer research. This booklet gives a brief overview of the early phase cancer research world and highlights...
Brand Guidelines
Basic page
Brand guidelines The Brand Guidelines document includes guidance on: Brand principles Our logos Our colour palette Our fonts Best practice examples If you are creating materials (such as leaflets or banners), they should be sent to ecmcadmin@cancer.org.uk for final approval. You can download our guidelines here or by clicking the...
International Clinical Trials Day 2018
News
To celebrate International Clinical Trials Day 2018 the Cancer Research UK Centre for Drug Development (CDD) are recognising staff who work across clinical trials by awarding them with a 'CDD Clinical Trial Heroes Award'. This years recipients include members from the ECMC network.